Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Global Geriatric Medicines Market

Published Date : Apr 2024

Global geriatric medicines market is estimated to be valued at USD 1,004.71 Bn in 2024 and is expected to reach USD 1,570.18 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031. Geriatric medicines refer to the medical products that a... View more

Coherent Market Insights Iron Deficiency Anemia Treatment Market

Published Date : Apr 2024

Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to exhibit a CAGR of 8.6% during the forecast period (2024-2031). Iron deficiency anemia is a very common nutritional deficiency that affects over a billion... View more

Coherent Market Insights Gastric Motility Disorder Drug Market

Published Date : Apr 2024

The global gastric motility disorder drug market is estimated to be valued at USD 57.65 Bn in 2024 and is expected to exhibit a CAGR of 5.4% during the forecast period (2024-2031). Gastric motility disorder refers to conditions wherein the stomach takes more or less t... View more

Coherent Market Insights Concierge Medicine Market

Published Date : Apr 2024

The global concierge medicine market is estimated to be valued at USD 19.86 BN in 2024 and is expected to exhibit a CAGR of 9.7% during the forecast period (2024-2031). Concierge medicine, also known as boutique medicine or retainer-based medicine, is a healthcare mod... View more

Coherent Market Insights Dry Eye Disease Market

Published Date : Apr 2024

The global dry eye disease market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to exhibit a CAGR of 8.8% during the forecast period (2024-2031). Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and... View more

Coherent Market Insights Diabetic Kidney Disease Market

Published Date : Apr 2024

Global diabetic kidney disease market is estimated to be valued at USD 3.03 Bn in 2024 and is expected to exhibit a CAGR of 4.8% during the forecast period (2024-2031). Diabetic kidney disease (DKD) is a condition in which the kidneys are damaged due to long-standing ... View more

Coherent Market Insights Dermocosmetics Skin Care Products Market

Published Date : Apr 2024

The global dermocosmetics skin care products market is estimated to be valued at USD 56.94 BN in 2024 and is expected to exhibit a CAGR of 8.1% during the forecast period (2024-2031). Dermocosmetics refer to topically applied cosmetic products that are designed especi... View more

Coherent Market Insights Aesthetic Injectables Market

Published Date : Mar 2024

The global aesthetic injectables market is estimated to be valued at USD 9.01 Bn in 2024 and is expected to exhibit a CAGR of 11.9% during the forecast period (2024-2031). The aesthetic injectables market has been growing at a rapid pace over the past few years. Aesth... View more

Coherent Market Insights Global Pharmaceutical Chemicals Market

Published Date : Mar 2024

The global pharmaceutical chemicals market is estimated to be valued at USD 137.76 Bn in 2024 and is expected to exhibit a CAGR of 7.2% during the forecast period (2024-2031). Pharmaceutical chemicals are chemical substances or a combination of substances that are use... View more

Coherent Market Insights Wellness Supplements Market

Published Date : Mar 2024

The global wellness supplements market is estimated to be valued at USD 270.10 Bn in 2024 and is expected to exhibit a CAGR of 7.7% during the forecast period (2024-2031). The global wellness supplements market has seen significant growth over the past decade. Growing... View more

Coherent Market Insights Global Synthetic Biosensors Market

Published Date : Mar 2024

The global synthetic biosensors market is estimated to be valued at USD 27.94 Bn in 2024 and is expected to exhibit a CAGR of 7.3%  during the forecast period (2024-2031). Synthetic biosensors have emerged as an important tool in biotechnology and biomedicine. Th... View more

Coherent Market Insights Uterine Fibroids Treatment Drugs Market

Published Date : Mar 2024

The global uterine fibroids treatment drugs market is estimated to be valued at USD 1.87 Bn in 2024 and is expected to exhibit a CAGR of 7.9% during the forecast period (2024-2031). Uterine fibroids are non-cancerous tumors that grow in or on a woman's uterus. Symptom... View more

Coherent Market Insights Otc Consumer Health Market

Published Date : Mar 2024

Over-the-counter (OTC) medicines are drugs that are available without a prescription. Some OTC medicines are used to relieve aches, pains, and itches. Some prevent or cure diseases such as tooth decay and athlete's foot. Other OTC health products may help to manage re... View more

Coherent Market Insights Type 1 Diabetes Market

Published Date : Mar 2024

Global type 1 diabetes market is estimated to be valued at USD 15.95 BN in 2024 and is expected to exhibit a CAGR of 6.2% during the forecast period (2024-2031). Type 1 diabetes is an autoimmune disease where the pancreas produces little or no insulin. It results from... View more

Coherent Market Insights Topical Drug Delivery Market

Published Date : Mar 2024

The global topical drug delivery market is estimated to be valued at USD 124.90 BN in 2024 and is expected to exhibit a CAGR of 9.1% during the forecast period (2024-2031). Topical drug delivery refers to the administration of therapeutic compounds directly to the sit... View more

Coherent Market Insights Type 2 Diabetes Market

Published Date : Mar 2024

The global type 2 diabetes market is estimated to be valued at USD 39.87 BN in 2024 and is expected to exhibit a CAGR of 7.7% during the forecast period (2024-2031). Type 2 diabetes is a chronic metabolic disease characterized by high blood sugar levels due to insulin... View more

Coherent Market Insights Insulin Glargine Market

Published Date : Mar 2024

Global insulin glargine market is estimated to be valued at USD 5.45 BN in 2024 and is expected to exhibit a CAGR of 6.4% during the forecast period (2024-2031). Insulin glargine, also known as Lantus, is a long-acting basal insulin that is used for the treatment of d... View more

Coherent Market Insights Immunohistochemistry Market

Published Date : Mar 2024

The global immunohistochemistry market is estimated to be valued at USD 2.88 BN in 2024 and is expected to exhibit a CAGR of 6.5% during the forecast period (2024-2031). Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by ... View more

Coherent Market Insights Oncology Drugs Market

Published Date : Mar 2024

The global oncology drugs market is estimated to be valued at USD 231.56 BN in 2024 and is expected to exhibit a CAGR of 12.6% during the forecast period (2024-2031). Oncology drugs refer to medications that are used for treating cancerous tumors. The global oncology ... View more

Coherent Market Insights Naloxone Market

Published Date : Mar 2024

The global naloxone market is estimated to be valued at USD 1,341.5 MN in 2024 and is expected to exhibit a CAGR of 10.4% during the forecast period (2024-2031). Naloxone is an opioid antagonist used for the complete or partial reversal of opioid overdose. It works by... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.